Pioneering Solutions To Transform Lives
SWATI is a global research-oriented pharmaceutical company with a vision to take science to market. Headquartered in Mumbai, with a distinguished history spanning over five decades. Our commitment extends beyond expanding our product range, for the past twenty-five years, we have dedicated ourselves to addressing neglected diseases.
Commitment to Innovation in Product Development
SWATI has achieved a global milestone by being the first to introduce a generic version of a drug that had been exclusive to the United States for over 20 years, priced at USD 25,000 per treatment.
We have introduced this generic in India and several other countries at a significantly reduced price of approximately USD 1,200—representing just 5% of the original cost. In addition, SWATI holds patents for treatments targeting kidney-related diseases, addressing critical therapeutic gaps where no existing medications are available for patients in need.
Why People Trust Us
SWATI remains a trusted partner for organizations seeking superior quality, regulatory adherence, and competitive pricing. Our proven track record of excellence is underpinned by positive recommendations, transparent policies, equitable procedures and a steadfast commitment to maintaining the highest standards and values.
Our state-of-the-art facilities are subject to rigorous inspections and approvals from leading regulatory bodies, including the USFDA, COFEPRIS (Mexico), Korean MFDS, and WHO-GMP. We adhere to the latest global cGMP and ICH guidelines and comply with the stringent requirements of international regulatory agencies such as MHRA, PMDA, EDQM, TGA, and MCC.
Our Facilities
We operate several API and intermediate manufacturing sites throughout India and have extended our operations to include the production and commercialization of our proprietary finished formulations.
What People Say About Us
